The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Open accessAbstract
Increasing evidence links the gut microbiota with colorectal cancer. Metagenomic analyses indicate that symbiotic Fusobacterium spp. are associated with human colorectal carcinoma, but whether this is an indirect or causal link remains unclear. We find that Fusobacterium spp. are enriched in human colonic adenomas relative to surrounding tissues and in stool samples from colorectal adenoma and carcinoma patients compared to healthy subjects. Additionally, in the Apc(Min/+) mouse model of intestinal tumorigenesis, Fusobacterium nucleatum increases tumor multiplicity and selectively recruits tumor-infiltrating myeloid cells, which can promote tumor progression. Tumors from Apc(Min/+) mice exposed to F. nucleatum exhibit a proinflammatory expression signature that is shared with human fusobacteria-positive colorectal carcinomas. However, unlike other bacteria linked to colorectal carcinoma, F. nucleatum does not exacerbate colitis, enteritis, or inflammation-associated intestinal carcinogenesis. Collectively, these data suggest that, through recruitment of tumor-infiltrating immune cells, fusobacteria generate a proinflammatory microenvironment that is conducive for colorectal neoplasia progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The gut microbiome has been shown to have multiple effects on tumor biology, such as the transformation process, tumor progression, and the response to anticancer therapies including immunotherapy (21-29).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [22]
In the citing paper
“The activation of NF-kB promoted the transcription of pro-inflammatory cytokines such as TNF-α and IL-6, which may explain the accumulation of immunosuppressive myeloid cells in TME [59] (Fig. 2).”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [59]
In the citing paper
“Kostic et al. found a correlation between a high abundance of F. nucleatum and activated NF-κB in CRC.”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,338
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3024 · Cited by 3,159
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–132 of 132
Colorectal cancer: the facts in the case of the microbiota
Clay, S. L., Fonseca-Pereira, D., & Garrett, W. S. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155101 · Cited by 166
Self-citationPeriodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study
Michaud, D. S., Lu, J., Peacock-Villada, A. Y., Barber, J. R., Joshu, C. E., Prizment, A. E., Beck, J. D., Offenbacher, S., & Platz, E. A. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx278 · Cited by 171
Waclawiková, B., & El Aidy, S. (2018) · Pharmaceuticals · doi:10.3390/ph11030063 · Cited by 172
The microbiome and the hallmarks of cancer
Fulbright, L. E., Ellermann, M., & Arthur, J. C. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006480 · Cited by 164
Bacteriocin production: A relatively unharnessed probiotic trait?
Hegarty, J. W., Guinane, C. M., Ross, R. P., Hill, C., & Cotter, P. D. (2016) · F1000Research · doi:10.12688/f1000research.9615.1 · Cited by 141
Periodontal disease, tooth loss and colorectal cancer risk: results from the Nurses’ Health Study
Momen-Heravi, F., Babic, A., Tworoger, S. S., Zhang, L., Wu, K., Smith-Warner, S. A., Ogino, S., Chan, A. T., Meyerhardt, J., Giovannucci, E., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30486 · Cited by 137
Self-citationYang, Y., Cai, Q., Shu, X., Steinwandel, M. D., Blot, W. J., Zheng, W., & Long, J. (2019) · International Journal of Cancer · doi:10.1002/ijc.31941 · Cited by 135
Atanasova, K. R., & Yilmaz, Ö. (2014) · Molecular Oral Microbiology · doi:10.1111/omi.12047 · Cited by 129
Gut microbiota-mediated immunomodulation in tumor
Liu, X., Chen, Y., Zhang, S., & Dong, L. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01983-x · Cited by 112
Raisch, J., Rolhion, N., Dubois, A., Darfeuille-Michaud, A., & Bringer, M.-A. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2014.161 · Cited by 100
ZnO and TiO2 nanoparticles as novel antimicrobial agents for oral hygiene: a review
Khan, S. T., Al-Khedhairy, A. A., & Musarrat, J. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3074-6 · Cited by 100
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Cogdill, A. P., Gaudreau, P. O., Arora, R., Gopalakrishnan, V., & Wargo, J. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.09.007 · Cited by 98
Profiling of tumour-associated microbiota in human hepatocellular carcinoma
Komiyama, S., Yamada, T., Takemura, N., Kokudo, N., Hase, K., & Kawamura, Y. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-89963-1 · Cited by 96
Crosstalk between gut microbiota and Sirtuin-3 in colonic inflammation and tumorigenesis
Zhang, Y., Wang, X.-L., Zhou, M., Kang, C., Lang, H.-D., Chen, M.-T., Hui, S.-C., Wang, B., & Mi, M.-T. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-017-0002-0 · Cited by 78
From taxonomy to metabolic output: what factors define gut microbiome health?
Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73
Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis
Klimesova, K., Jiraskova Zakostelska, Z., & Tlaskalova-Hogenova, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00774 · Cited by 67
Jia, Y.-P., Wang, K., Zhang, Z.-J., Tong, Y.-N., Han, D., Hu, C.-Y., Li, Q., Xiang, Y., Mao, X.-H., & Tang, B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186179 · Cited by 65
Randrian, V., Evrard, C., & Tougeron, D. (2021) · Cancers · doi:10.3390/cancers13123063 · Cited by 65
Modulation of pathogenic oral biofilms towards health with nisin probiotic
Radaic, A., Ye, C., Parks, B., Gao, L., Kuraji, R., Malone, E., Kamarajan, P., Zhan, L., & Kapila, Y. L. (2020) · Journal of Oral Microbiology · doi:10.1080/20002297.2020.1809302 · Cited by 59
Borozan, I., Zaidi, S. H., Harrison, T. A., Phipps, A. I., Zheng, J., Lee, S., Trinh, Q. M., Steinfelder, R. S., Adams, J., Banbury, B. L., et al. (2022) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0463 · Cited by 57
Lehr, K., Nikitina, D., Vilchez-Vargas, R., Steponaitiene, R., Thon, C., Skieceviciene, J., Schanze, D., Zenker, M., Malfertheiner, P., Kupcinskas, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-31740-3 · Cited by 54
Gao, Z., Jiang, A., Li, Z., Zhu, L., Mou, W., Shen, W., Luo, P., Tang, B., Zhang, J., & Lin, A. (2025) · Med Research · doi:10.1002/mdr2.70006 · Cited by 51
The role of the gut microbiome in colorectal cancer: Where are we? Where are we going?
Wieczorska, K., Stolarek, M., & Stec, R. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2019.07.006 · Cited by 50
Lennard, K. S., Goosen, R. W., & Blackburn, J. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166282 · Cited by 45
Metabolic reprogramming: a bridge between aging and tumorigenesis
Drapela, S., Ilter, D., & Gomes, A. P. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13261 · Cited by 41
Gut microbiota imbalance and base excision repair dynamics in colon cancer
Ray, D., & Kidane, D. (2016) · Journal of Cancer · doi:10.7150/jca.15480 · Cited by 37
“For example, Fusobacterium nucleatum increases tumor multiplicity by the infiltration of immune cells and NF-κB activation that potentiate intestinal tumorigenesis [30].”
BackgroundHu, J.-M., Shen, C.-J., Chou, Y.-C., Hung, C.-F., Tian, Y.-F., You, S.-L., Chen, C.-Y., Hsu, C.-H., Hsiao, C.-W., Lin, C.-Y., et al. (2018) · International Journal of Colorectal Disease · doi:10.1007/s00384-018-2965-2 · Cited by 39
Galeano Niño, J. L., Wu, H., LaCourse, K. D., Srinivasan, H., Fitzgibbon, M., Minot, S. S., Sather, C., Johnston, C. D., & Bullman, S. (2023) · Nature Protocols · doi:10.1038/s41596-023-00888-7 · Cited by 36
Greathouse, K. L., White, J. R., Padgett, R. N., Perrotta, B. G., Jenkins, G. D., Chia, N., & Chen, J. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000247 · Cited by 35
Microbial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Araujo, D. V., Watson, G. A., Oliva, M., Heirali, A., Coburn, B., Spreafico, A., & Siu, L. L. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102125 · Cited by 29
Fusobacterium nucleatum carcinogenesis and drug delivery interventions
Chen, Z., & Huang, L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115319 · Cited by 27
Metadata
- Authors
- Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., El-Omar, E. M., Brenner, D., Fuchs, C. S., Meyerson, M., & Garrett, W. S.
- Affiliations
- Broad Institute (US)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- University of Aberdeen (GB)
- University of Michigan (US)
- Corresponding author
- Meyerson, Matthew
- Garrett, Wendy S.
- ORCID
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 14
- Issue
- 2
- Pages
- 207-215
- ISSN
- 1931-3128 (ISSN-L)
- PMC
- PMC3772512
- OpenAlex
- W2096139589
- Cited by
- 2,718
- References
- 43
- Citations by year
- 2026: 274 · 2025: 280 · 2024: 290 · 2023: 294 · 2022: 281 · 2021: 323 · 2020: 225 · 2019: 199 · 2018: 178 · 2017: 119 · 2016: 105 · 2015: 79 · 2014: 56 · 2013: 12
- FWCI
- 37.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Host & Microbe (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research Institute
- National Human Genome Research Institute (U54HG003067)
- National Cancer Institute (P50CA127003, RC2CA148317, R01CA154426)
- National Institute of Allergy and Infectious Diseases (K08AI078942)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311, P30DK043351)
- National Institute of Environmental Health Sciences (T32ES016645)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- Fusobacterium nucleatum, colorectal cancer, colorectal adenoma, gut microbiota, intestinal tumorigenesis, tumor microenvironment, tumor-infiltrating myeloid cells, pro-inflammatory microenvironment, ApcMin/+ mice, colonic neoplasia, inflammation-associated carcinogenesis
- MeSH terms
- Adenoma, Animals, Disease Models, Animal, Humans, Leukocytes, Colorectal Neoplasms, Cytokines, Fusobacterium nucleatum, Mice, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
